{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T15:01:56Z","timestamp":1784127716494,"version":"3.55.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002947","name":"Anhui Medical University","doi-asserted-by":"publisher","award":["PJ20231438"],"award-info":[{"award-number":["PJ20231438"]}],"id":[{"id":"10.13039\/501100002947","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.intimp.2024.113399","type":"journal-article","created":{"date-parts":[[2024,10,16]],"date-time":"2024-10-16T20:15:25Z","timestamp":1729109725000},"page":"113399","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"P2","title":["CARD9 promotes cholangiocarcinoma by regulating the IL-17A\/Hedgehog and the THEM4\/AKT\/mTOR signaling pathways"],"prefix":"10.1016","volume":"143","author":[{"given":"Tao","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Xin","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi-Kai","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Jian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye-Ben","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.intimp.2024.113399_b0005","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.canlet.2016.05.038","article-title":"Expression of transforming growth factor \u03b21 promotes cholangiocarcinoma development and progression","volume":"380","author":"Huang","year":"2016","journal-title":"Cancer Lett."},{"key":"10.1016\/j.intimp.2024.113399_b0010","doi-asserted-by":"crossref","first-page":"136","DOI":"10.4251\/wjgo.v2.i3.136","article-title":"New insights on cholangiocarcinoma","volume":"2","author":"Gatto","year":"2010","journal-title":"World J. Gastrointest. Oncol."},{"key":"10.1016\/j.intimp.2024.113399_b0015","first-page":"1469","article-title":"Cholangiocarcinoma: new insights","volume":"18","author":"Goral","year":"2017","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"10.1016\/j.intimp.2024.113399_b0020","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/s41575-020-0310-z","article-title":"Cholangiocarcinoma 2020: the next horizon in mechanisms and management","volume":"17","author":"Banales","year":"2020","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.intimp.2024.113399_b0025","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/ncpgasthep0389","article-title":"Cholangiocarcinoma","volume":"3","author":"Patel","year":"2006","journal-title":"Nat. Clin. Pract. Gastroenterol. Hepatol."},{"issue":"2","key":"10.1016\/j.intimp.2024.113399_b0030","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/nrclinonc.2017.157","article-title":"Cholangiocarcinoma - evolving concepts and therapeutic strategies","volume":"15","author":"Rizvi","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.intimp.2024.113399_b0035","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1242\/dmm.010561","article-title":"The challenge of cholangiocarcinoma: dissecting the molecular mechanisms of an insidious cancer","volume":"6","author":"Zabron","year":"2013","journal-title":"Model Mech."},{"key":"10.1016\/j.intimp.2024.113399_b0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.108402","article-title":"The role of IL-17 and anti-IL-17 agents in the immunopathogenesis and management of autoimmune and inflammatory diseases","volume":"102","author":"Berry","year":"2022","journal-title":"Int. Immunopharmacol."},{"issue":"1","key":"10.1016\/j.intimp.2024.113399_b0045","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-001895","article-title":"Blocking IL-17A enhances tumor response to anti-PD-1 immunotherapy in microsatellite stable colorectal cancer","volume":"9","author":"Liu","year":"2021","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.intimp.2024.113399_b0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2022.215977","article-title":"IFN\u03b3-IL-17+ CD8 T cells contribute to immunosuppression and tumor progression in human hepatocellular carcinoma","volume":"552","author":"Lee","year":"2023","journal-title":"Cancer Lett."},{"key":"10.1016\/j.intimp.2024.113399_b0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.107544","article-title":"The potential role and status of IL-17 family cytokines in breast cancer","volume":"95","author":"Song","year":"2021","journal-title":"Int. Immunopharmacol."},{"issue":"9","key":"10.1016\/j.intimp.2024.113399_b0060","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/s41419-022-05215-8","article-title":"Cathepsin K regulates the tumor growth and metastasis by IL-17\/CTSK\/EMT axis and mediates M2 macrophage polarization in castration-resistant prostate cancer","volume":"13","author":"Wu","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.intimp.2024.113399_b0065","doi-asserted-by":"crossref","first-page":"S1524","DOI":"10.1245\/s10434-015-4782-y","article-title":"Prognostic impact of peritumoral IL-17-positive cells and IL-17 axis in patients with intrahepatic cholangiocarcinoma","volume":"22","author":"Asukai","year":"2015","journal-title":"Ann. Surg. Oncol."},{"issue":"3","key":"10.1016\/j.intimp.2024.113399_b0070","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.21037\/jgo-22-298","article-title":"Effects of 2-dodecyl-6-methoxycyclohexa-2,5-diene-1,4-dione on autophagy and the PI3K\/AKT\/mTOR signaling pathway in human cholangiocarcinoma QBC939 cells","volume":"13","author":"He","year":"2022","journal-title":"J. Gastrointest. Oncol."},{"issue":"11","key":"10.1016\/j.intimp.2024.113399_b0075","article-title":"Exosomal miR-183-5p shuttled by M2 polarized tumor-associated macrophage promotes the development of colon cancer via targeting THEM4 mediated PI3K\/AKT and NF-\u03baB pathways","volume":"25","author":"Zhang","year":"2021","journal-title":"Front. Oncol."},{"issue":"17","key":"10.1016\/j.intimp.2024.113399_b0080","doi-asserted-by":"crossref","first-page":"11681","DOI":"10.1074\/jbc.M113.517581","article-title":"Vitamin D inhibits COX-2 expression and inflammatory response by targeting thioesterase superfamily member 4","volume":"289","author":"Wang","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.intimp.2024.113399_b0085","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/s41419-017-0084-6","article-title":"Molecular and physiological roles of the adaptor protein CARD9 in immunity","volume":"9","author":"Zhong","year":"2018","journal-title":"Cell Death Dis."},{"issue":"13","key":"10.1016\/j.intimp.2024.113399_b0090","article-title":"CARD9 signaling, inflammation, and diseases","volume":"30","author":"Liu","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2024.113399_b0095","doi-asserted-by":"crossref","first-page":"3632549","DOI":"10.1155\/2022\/3632549","article-title":"Chidamide suppresses the growth of cholangiocarcinoma by inhibiting HDAC3 and promoting FOXO1 acetylation","volume":"2022","author":"Li","year":"2022","journal-title":"Stem Cells Int."},{"issue":"7","key":"10.1016\/j.intimp.2024.113399_b0100","article-title":"IL-17 promotes melanoma through TRAF2 as a scaffold protein recruiting PIAS2 and ELAVL1 to induce EPHA5","volume":"1870","author":"Du","year":"2023","journal-title":"Biochim. Biophys. Acta"},{"issue":"5","key":"10.1016\/j.intimp.2024.113399_b0105","doi-asserted-by":"crossref","first-page":"100737","DOI":"10.1016\/j.aohep.2022.100737","article-title":"Clinical treatment of cholangiocarcinoma: an updated comprehensive review","volume":"27","author":"Elvevi","year":"2022","journal-title":"Ann. Hepatol."},{"issue":"1","key":"10.1016\/j.intimp.2024.113399_b0110","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/s41572-021-00300-2","article-title":"Cholangiocarcinoma","volume":"7","author":"Brindley","year":"2021","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.intimp.2024.113399_b0115","article-title":"CARD9 signaling, inflammation, and diseases","volume":"13","author":"Liu","year":"2022","journal-title":"Front. Immunol."},{"issue":"8","key":"10.1016\/j.intimp.2024.113399_b0120","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1038\/cdd.2014.45","article-title":"Tumor cell-activated CARD9 signaling contributes to metastasis-associated macrophage polarization","volume":"21","author":"Yang","year":"2014","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.intimp.2024.113399_b0125","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1158\/2326-6066.CIR-14-0148","article-title":"CARD9 promotes sex-biased colon tumors in the APCmin mouse model","volume":"3","author":"Leo","year":"2015","journal-title":"Cancer Immunol. Res."},{"issue":"5","key":"10.1016\/j.intimp.2024.113399_b0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.aohep.2022.100737","article-title":"Clinical treatment of cholangiocarcinoma: an updated comprehensive review","volume":"27","author":"Elvevi","year":"2022","journal-title":"Ann. Hepatol."},{"issue":"12","key":"10.1016\/j.intimp.2024.113399_b0135","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1002\/ijc.34350","article-title":"Cholangiocarcinoma cell proliferation is enhanced in primary sclerosing cholangitis: a role for IL-17A","volume":"152","author":"Lieshout","year":"2023","journal-title":"Int. J. Cancer"},{"issue":"1","key":"10.1016\/j.intimp.2024.113399_b0140","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s13046-018-1003-0","article-title":"Tumor-associated neutrophils induce EMT by IL-17a to promote migration and invasion in gastric cancer cells","volume":"38","author":"Li","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"8","key":"10.1016\/j.intimp.2024.113399_b0145","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1136\/gutjnl-2022-327855","article-title":"IL-17A-producing CD8+ T cells promote PDAC via induction of inflammatory cancer-associated fibroblasts","volume":"72","author":"Picard","year":"2023","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.intimp.2024.113399_b0150","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.ydbio.2017.10.022","article-title":"Cell cycle-related kinase regulates mammalian eye development through positive and negative regulation of the Hedgehog pathway","volume":"434","author":"Lupu","year":"2018","journal-title":"Dev. Biol."},{"issue":"1","key":"10.1016\/j.intimp.2024.113399_b0155","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s00784-018-2421-2","article-title":"Immunohistochemical evaluation of Sonic Hedgehog signaling pathway proteins (Shh, Ptch1, Ptch2, Smo, Gli1, Gli2, and Gli3) in sporadic and syndromic odontogenic keratocysts","volume":"23","author":"Hoyos Cadavid","year":"2019","journal-title":"Clin. Oral Invest."},{"issue":"1","key":"10.1016\/j.intimp.2024.113399_b0160","first-page":"275","article-title":"Fibroblast activation protein-\u03b1 promotes the growth and migration of lung cancer cells via the PI3K and sonic hedgehog pathways","volume":"41","author":"Jia","year":"2018","journal-title":"Int. J. Mol. Med."},{"issue":"2","key":"10.1016\/j.intimp.2024.113399_b0165","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s40264-018-0777-5","article-title":"Safety and tolerability of sonic hedgehog pathway inhibitors in cancer","volume":"42","author":"Carpenter","year":"2019","journal-title":"Drug Saf."},{"issue":"9","key":"10.1016\/j.intimp.2024.113399_b0170","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1038\/ni.2081","article-title":"Treatment with IL-17 prolongs the half-life of chemokine CXCL1 mRNA via the adaptor TRAF5 and the splicing-regulatory factor SF2 (ASF)","volume":"12","author":"Sun","year":"2011","journal-title":"Nat. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2024.113399_b0175","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1158\/1541-7786.MCR-11-0337","article-title":"The mRNA stability factor HuR inhibits microRNA-16 targeting of COX-2","volume":"10","author":"Young","year":"2012","journal-title":"Mol. Cancer Res."},{"issue":"3","key":"10.1016\/j.intimp.2024.113399_b0180","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/cgt.2013.6","article-title":"Co-delivery of LETM1 and CTMP synergistically inhibits tumor growth in H-ras12V liver cancer model mice","volume":"20","author":"Shin","year":"2013","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.intimp.2024.113399_b0185","article-title":"Exosomal miR-183-5p shuttled by M2 polarized tumor-associated macrophage promotes the development of colon cancer via targeting THEM4 mediated PI3K\/AKT and NF-\u03baB pathways","volume":"11","author":"Zhang","year":"2021","journal-title":"Front. Oncol."},{"issue":"23","key":"10.1016\/j.intimp.2024.113399_b0190","doi-asserted-by":"crossref","first-page":"5889","DOI":"10.1158\/0008-5472.CAN-21-1538","article-title":"A PLCB1-PI3K-AKT signaling axis activates EMT to promote cholangiocarcinoma progression","volume":"81","author":"Liang","year":"2021","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.intimp.2024.113399_b0195","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.jhep.2019.11.021","article-title":"MUC13 promotes intrahepatic cholangiocarcinoma progression via EGFR\/PI3K\/AKT pathways","volume":"72","author":"Pei","year":"2020","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.intimp.2024.113399_b0200","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2478\/jtim-2021-0043","article-title":"Dysregulation of MiR-144-5p\/RNF187 axis contributes to the progression of colorectal cancer","volume":"10","author":"Gao","year":"2022","journal-title":"J. Transl. Int. Med."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924019210?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924019210?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T02:31:55Z","timestamp":1736303515000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576924019210"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":40,"alternative-id":["S1567576924019210"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2024.113399","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CARD9 promotes cholangiocarcinoma by regulating the IL-17A\/Hedgehog and the THEM4\/AKT\/mTOR signaling pathways","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2024.113399","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"113399"}}